Orgenesis : Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 to Regain Compliance With Bid Price and Equity Rules
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.